Clinical trial Recruiting at 2 sites Phase1; Phase2 Interventional Ages 21 to 80

Treatment for hair loss and skin rejuvenation using fat-derived cells

Official title: Autologous Adipose Cells Therapy

Run by Cerm INC. · NCT06869252 · Data updated 2026-11-12

This study is testing a new treatment using fat cells to see if it can help people with hair loss and improve their skin's appearance.

More Skin Elasticity trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages21 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorCerm INC.
Industry-sponsored
Locations2 sites (Lewes, Delaware and 1 other locations)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedNovember 1, 2025
Study endsFebruary 1, 2026
Registry record updatedMay 31, 2025
Trial IDNCT06869252 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 21 to 80 experiencing skin aging signs or hair loss.

Probably not a fit

Patients with chronic diseases, active infections, or a history of cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the safety and efficacy of Autologous Adipose Cell Therapy, which aims to improve skin rejuvenation and hair restoration by isolating early-stage adipose cells from lipoaspirate. The approach seeks to enhance traditional autologous fat grafting and dermal fillers by optimizing the number of adipocytes, potentially leading to longer-lasting aesthetic outcomes. Participants will undergo procedures designed to assess the feasibility of this innovative therapy in addressing conditions such as wrinkles, fine lines, and hair thinning.

Why it matters

Potential benefit: If successful, this therapy could provide patients with more effective and longer-lasting solutions for hair loss and skin rejuvenation.

How similar studies have gone: Other studies have shown promise with similar approaches in fat grafting and cell therapy, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Outpatients who express interest in skin rejuvenation, and/or who are experiencing skin conditions, such as winkles, fine lines, loss of skin elasticity, skin pigmentation, scarring.
2. Outpatients who are experiencing hair loss or hair thinning
3. Provision of signed and dated informed consent form
4. Clearly stated willingness to comply with all the procedures of the study and availability of the study
5. Female and Male aged between 21 to 80 years old 6 Medical clearance by family doctor

Exclusion Criteria:

1. Pregnancy or lactation
2. Known allergic reaction to components of cell culture media
3. Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures
4. Chronic infections, e.g. skin fungi infection, psoriasis
5. Chronic wound healing
6. Currently taking hormone therapy
7. History of cancers and active cancers
8. Viral infection, e.g. HIV, hepatitis B, influenza, coronaviruses.

Where it's running

  • The Centre for Cosmetic Surgery & Medicine, Newark
    Lewes, Delaware, United States
    Recruiting
  • The Centre for Cosmetic Surgery & Medicine
    Newark, Delaware, United States
    Recruiting

Study contacts

  • Principal investigator: Dr. Abdollah M. Malekzadeh, MD, MD — The Centre for Cosmetic Surgery & Medicine
  • Study coordinator: Ankeet Dixit
  • Email: ankeetdixit@cermbio.com
  • Phone: 813-992-2521

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.